Sai Life Sciences IPO: Issue Date, Price Band, GMP, Minimum Investment, Lot Size, Read Here

The Initial Public Offering (IPO) of Sai Life Sciences opened for subscription on Wednesday, December 11. The company is a contract research, development, and manufacturing organization (CRDMO) that helps pharmaceutical and biotechnology companies discover, develop, and manufacture small molecules. 

Sai Life Sciences IPO: Issue Size

Sai Life Sciences IPO is a book-built issue of Rs 3,042.62 crores. The issue is a combination of a fresh issue of 1.73 crore shares aggregating to Rs 950.00 crores and an offer for sale of 3.81 crore shares aggregating to Rs 2,092.62 crore.

Sai Life Sciences IPO: Key Dates To Remember

IPO Open Date, Wednesday, December 11, 2024
IPO Close Date,  Friday, December 13, 2024
Basis of Allotment, Monday, December 16, 2024
Initiation of Refunds, Tuesday, December 17, 2024
Credit of Shares to Demat, Tuesday, December 17, 2024
Listing Date Wednesday, December 18, 2024
 

Sai Life Sciences IPO: Details

Face Value              Rs 1 per share
Price Band              Rs 522 to Rs 549 per share
Lot Size                  Minimum 27 Shares
Total Issue Size       55,421,123 shares
(aggregating up to Rs3,042.62 Cr)
Fresh Issue             17,304,189 shares
(aggregating up to Rs950.00 Cr)
Offer for Sale         38,116,934 shares of Re1
(aggregating up to Rs2,092.62 Cr)
Issue Type              Book Built Issue IPO
Listing At                BSE, NSE 
 

SaSai Life Sciences IPO GMP Today

Life Sciences IPO latest GMP is between Rs 35 and 40, last updated Dec 12 2024, at 11:01 am. GMP or Grey Market Premium is the price that the secondary market is willing to pay for an issue above the upper price in its price band.

Sai Life Sciences IPO: Managers

Book Running Lead Managers of the IPO are Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited, Jefferies India Private Limited, and Morgan Stanley India Company Private Limited, and the sponsor banks are  HDFC Bank Limited and Axis Bank Limited.

Sai Life Sciences is a contract research, development, and manufacturing organization (CRDMO) that helps pharmaceutical and biotechnology companies discover, develop, and manufacture small molecules. Sai Life Sciences has R&D and manufacturing sites in India, the UK, and the USA.